Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pileri

Showing results (811-820 of 992) with videos related to

Pageof 100
Sort By:
Leukemia|March 26, 2014
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphomaP Corradini, U Vitolo, A Rambaldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2008
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi surveyCorrado Tarella, Manuela Zanni, Michele Magni, et al.
Hematological Oncology|August 31, 2023
Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panelPietro Quaglino, Nicola Pimpinelli, Pier Luigi Zinzani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 1998
Pyothorax-associated lymphoma: description of the first two cases detected in ItalyS Ascani, M Piccioli, S Poggi, et al.
The Journal of Pathology|June 2, 2006
Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomasS Tedoldi, J C Paterson, J Cordell, et al.
Clinical Science (London, England : 1979)|May 19, 2020
Deregulation of miRNAs-cMYC circuits is a key event in refractory celiac disease type-2 lymphomagenesisValentina Vaira, Gabriella Gaudioso, Maria Antonella Laginestra, et al.
Frontiers in Oncology|December 23, 2021
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana LinfomiLaura Ballotta, Pier Luigi Zinzani, Stefano Pileri, et al.
Cancers|July 2, 2021
T-Cell Lymphoblastic Lymphoma Arising in the Setting of Myeloid/Lymphoid Neoplasms with Eosinophilia: LMO2 Immunohistochemistry as a Potentially Useful Diagnostic MarkerMagda Zanelli, Giuseppe G Loscocco, Elena Sabattini, et al.
British Journal of Haematology|March 17, 2026
Mediastinal grey zone lymphomas: Results of the expert pathological review analysis of a case series enrolled in the multicentre BIOGZL-2020 study in ItalyElena Sabattini, Stefano Ascani, Sabino Ciavarella, et al.
Histopathology|June 22, 2012
IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomasBrunangelo Falini, Claudio Agostinelli, Barbara Bigerna, et al.
Pageof 100

Showing results (811-820 of 992) with videos related to

Sort By:
Pageof 100
Leukemia|March 26, 2014
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphomaP Corradini, U Vitolo, A Rambaldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2008
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi surveyCorrado Tarella, Manuela Zanni, Michele Magni, et al.
Hematological Oncology|August 31, 2023
Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panelPietro Quaglino, Nicola Pimpinelli, Pier Luigi Zinzani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 1998
Pyothorax-associated lymphoma: description of the first two cases detected in ItalyS Ascani, M Piccioli, S Poggi, et al.
The Journal of Pathology|June 2, 2006
Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomasS Tedoldi, J C Paterson, J Cordell, et al.
Clinical Science (London, England : 1979)|May 19, 2020
Deregulation of miRNAs-cMYC circuits is a key event in refractory celiac disease type-2 lymphomagenesisValentina Vaira, Gabriella Gaudioso, Maria Antonella Laginestra, et al.
Frontiers in Oncology|December 23, 2021
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana LinfomiLaura Ballotta, Pier Luigi Zinzani, Stefano Pileri, et al.
Cancers|July 2, 2021
T-Cell Lymphoblastic Lymphoma Arising in the Setting of Myeloid/Lymphoid Neoplasms with Eosinophilia: LMO2 Immunohistochemistry as a Potentially Useful Diagnostic MarkerMagda Zanelli, Giuseppe G Loscocco, Elena Sabattini, et al.
British Journal of Haematology|March 17, 2026
Mediastinal grey zone lymphomas: Results of the expert pathological review analysis of a case series enrolled in the multicentre BIOGZL-2020 study in ItalyElena Sabattini, Stefano Ascani, Sabino Ciavarella, et al.
Histopathology|June 22, 2012
IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomasBrunangelo Falini, Claudio Agostinelli, Barbara Bigerna, et al.
Pageof 100